Kilkenny Renounces to the Proposed Transaction with DNA Canada Inc.
(firmenpresse) - MONTREAL, QUEBEC -- (Marketwired) -- 10/24/16 -- Kilkenny Capital Corporation (the "Corporation" or "Kilkenny")(NEX: KIK.H), announced that it has terminated its contractual relationship with DNA Canada Inc. ("DNA") related to the proposed Qualifying Transaction announced in a press release dated July 17, 2015.
DNA was not able to complete the necessary steps to allow the resulting company to meet its operation and growth objectives.
Kilkenny confirms that it resumes right now its process of identifying and evaluating businesses and assets with a view to completing a transaction which will meet the initial listing requirements of the TSX Venture Exchange.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
Mr. Marcel Bergeron
President, Chief Executive Officer,
Chief Financial Officer and Secretary
(514) 232-3344
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 24.10.2016 - 21:27 Uhr
Sprache: Deutsch
News-ID 502441
Anzahl Zeichen: 0
contact information:
Town:
MONTREAL, QUEBEC
Kategorie:
Investment Services & Trading
Diese Pressemitteilung wurde bisher 329 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Kilkenny Renounces to the Proposed Transaction with DNA Canada Inc."
steht unter der journalistisch-redaktionellen Verantwortung von
Kilkenny Capital Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
